NeoPharm Revenue vs. Shares Owned By Insiders
| 092730 Stock | KRW 11,860 120.00 1.00% |
For NeoPharm profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NeoPharm to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NeoPharm LTD utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NeoPharm's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NeoPharm LTD over time as well as its relative position and ranking within its peers.
NeoPharm |
NeoPharm LTD Shares Owned By Insiders vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NeoPharm's current stock value. Our valuation model uses many indicators to compare NeoPharm value to that of its competitors to determine the firm's financial worth. NeoPharm LTD is the top company in revenue category among its peers. It also is number one stock in shares owned by insiders category among its peers . The ratio of Revenue to Shares Owned By Insiders for NeoPharm LTD is about 2,258,107,851 . Comparative valuation analysis is a catch-all model that can be used if you cannot value NeoPharm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NeoPharm's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NeoPharm Revenue vs. Competition
NeoPharm LTD is the top company in revenue category among its peers. Market size based on revenue of Consumer Staples industry is presently estimated at about 1.24 Trillion. NeoPharm holds roughly 87.93 Billion in revenue claiming about 7% of stocks in Consumer Staples industry.
NeoPharm Shares Owned By Insiders vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
NeoPharm |
| = | 87.93 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
NeoPharm |
| = | 38.94 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
NeoPharm Shares Owned By Insiders Comparison
NeoPharm is currently under evaluation in shares owned by insiders category among its peers.
NeoPharm Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NeoPharm, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NeoPharm will eventually generate negative long term returns. The profitability progress is the general direction of NeoPharm's change in net profit over the period of time. It can combine multiple indicators of NeoPharm, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
NeoPharm Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NeoPharm. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NeoPharm position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NeoPharm's important profitability drivers and their relationship over time.
Use NeoPharm in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeoPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoPharm will appreciate offsetting losses from the drop in the long position's value.NeoPharm Pair Trading
NeoPharm LTD Pair Trading Analysis
The ability to find closely correlated positions to NeoPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeoPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeoPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeoPharm LTD to buy it.
The correlation of NeoPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoPharm LTD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeoPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your NeoPharm position
In addition to having NeoPharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Retail Thematic Idea Now
Retail
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in NeoPharm Stock
To fully project NeoPharm's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NeoPharm LTD at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NeoPharm's income statement, its balance sheet, and the statement of cash flows.